Gonarthrosis [arthrosis of knee]. Primary gonarthrosis, bilateral
Conditions
Interventions
first group: Injection of 5 cc PRP (tubex, super PRP tube system) in the knee intraarticularly.
second group: injection of 40 mg corticosteroid (Depomedrol) in the knee intraarticularly.
Intervention 1: first group: Injection of 5 cc PRP (tubex, super PRP tube system) in the knee intraarticularly. Intervention 2: second group: injection of 40 mg corticosteroid (Depomedrol) in the knee
Treatment - Drugs
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion: knee osteoarthritis; VAS more than 60; use of at least two other methods of treatment previously. Exclusion: breast feeding; pregnancy; RA; severe cardiac disease; immunosuppresion; warfarin intake; coagulopathies; take NSAID or ASA during 5 days ago; radiculopathy; knee surgery during 3 months ago; active infection or malignancy; substance abuse; poor controlled diabetes mellitus; any knee injection during 6 months ago; doing physiotherapy or acupuncture during 6 months after injection
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: before injection, 3 weeks, 2 and 6 months after injection. Method of measurement: VAS.;Time of 20 meters traverse. Timepoint: before injection, 3 weeks, 2 and 6 months after injection. Method of measurement: 20 meteres walk test.;Pain, symptomes and function of patient. Timepoint: before injection, 2 and 6 months after injection. Method of measurement: KOOS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Bijan Forogh
Tehran University of Medical Sciences
Outcome results
None listed